Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer

Pancreatic cancer (PC) is burdened with a low 5-year survival rate and high mortality due to a severe lack of early diagnosis methods and slow progress in treatment options. To improve clinical diagnosis and enhance the treatment effects, we applied metabolomics using ultra-high-performance liquid c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Qin, Henan, Liu, Huiying, Wei, Tianfu, Wu, Zeming, Shang, Mengxue, Liu, Haihua, Wang, Aman, Liu, Jiwei, Shang, Dong, Yin, Peiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479084/
https://www.ncbi.nlm.nih.gov/pubmed/36119530
http://dx.doi.org/10.3389/fonc.2022.991051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479084/
https://www.ncbi.nlm.nih.gov/pubmed/36119530
http://dx.doi.org/10.3389/fonc.2022.991051

Ejemplares similares